NCT06651229
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06651229
Title A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | ESP | AUS

Facility Status City State Zip Country Details
Concord Hospital Concord 2139 Australia Details
Peter MacCallum Cancer Centre Melbourne 3000 Australia Details
Sir Charles Gairdner Hospital Nedlands 6009 Australia Details
Institut Paoli-Calmettes Marseille 13273 France Details
CHRU de Strasbourg - Hopital de Hautepierre Strasbourg 67200 France Details
Institut Claudius Regaud Toulouse 31100 France Details
Hosp Univ Fund Jimenez Diaz Madrid 28040 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Hospital Universitario Virgen Rocio Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field